Market revenue in 2023 | USD 6.8 million |
Market revenue in 2030 | USD 9.3 million |
Growth rate | 4.5% (CAGR from 2023 to 2030) |
Largest segment | Transbronchial needle aspiration (tbna) needles |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 61.76% in 2023. Horizon Databook has segmented the Sweden bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
The bronchial biopsy devices market growth in Sweden can be attributed to the country’s advanced healthcare system, which ranks among the best globally for accessibility and quality. Sweden’s focus on preventive healthcare, particularly in detecting respiratory conditions early, is expected to drive the adoption of advanced bronchial biopsy devices.
Leading Swedish hospitals, such as Karolinska University Hospital in Stockholm, are at the forefront of integrating cutting-edge diagnostic technologies into their practices. Sweden has a relatively low incidence of lung cancer compared to other European countries; however, the demand for accurate diagnostic tools remains strong due to the country’s aging population.
Swedish medical device companies, including Elekta, contribute to the market by developing high-quality diagnostic equipment tailored to local needs. Moreover, the Swedish government’s commitment to healthcare innovation is evident through substantial investments in R&D, often in collaboration with universities like Uppsala University, known for its work in medical technologies.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden bronchial biopsy devices market , including forecasts for subscribers. This country databook contains high-level insights into Sweden bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account